Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Belladonna, also known as Deadly Nightshade or *Atropa belladonna*, is a highly potent and toxic plant that has been historically used in both traditional and homeopathic medicine. Its toxicity stems from tropane alkaloids such as atropine, scopolamine, and hyoscyamine, which are potent anticholinergic agents. In homeopathy, belladonna is prepared in highly diluted forms, such as Belladonna 7cH, and is used based on the principle of "like cures like" to treat conditions with sudden, intense symptoms like fever, inflammation, and pain. A randomized, double-blind, placebo-controlled clinical trial investigated Belladonna 7cH, in association with X-ray 15cH, for the treatment of acute radiodermatitis in breast cancer patients undergoing radiotherapy. The study found a statistically significant benefit of the homeopathic medicine over placebo during the recovery phase, particularly in reducing skin warmth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on belladonna.